Targeted Therapies and Developing Precision Medicine in Gastric Cancer
Rille Pihlak, Caroline Fong, Naureen Starling
Abstract
Gastric cancer is an aggressive disease with survival remaining poor in the advanced setting. More than a decade after the first targeted treatment was approved, still only HER2, MSI and PDL-1 status have reached everyday practice in terms of guiding treatment options for these patients. However, various new targets and novel treatments have recently been investigated and have shown promise in improving survival outcomes. In this review, we will summarise previous and currently ongoing studies on predictive biomarkers, possible new targeted treatments, potential reasons for conflicting trial results and hope for the future of precision medicine in gastric cancer.
Topics & Concepts
MedicinePrecision medicineCancerTargeted therapyIntensive care medicineDiseaseAlternative medicineOncologyInternal medicinePathologyGastric Cancer Management and OutcomesColorectal Cancer Treatments and StudiesHelicobacter pylori-related gastroenterology studies